The Third Annual Cardiovascular Disease in African-Americans Conference

April 211 - 5:30 p.m.

The Ohio State University’s Biomedical Research Tower Auditorium460 W. 12th Ave.Columbus

FeaturingClyde Yancy, MD, MSc Northwestern Memorial Hospital Northwestern Feinberg School of Medicine

Herman Taylor, MD, MPHUniversity of Mississippi Medical CenterJackson State University

Sponsored by: The Ohio State University Medical Center in Cooperation with

Ohio State’s Heart and Vascular Center and Division of Cardiovascular Medicine

The Third Annual Cardiovascular Disease in African-Americans Conference

April 211 - 5:30 p.m.

The Ohio State University’s Biomedical Research Tower Auditorium460 W. 12th Ave.Columbus

Like all Americans, the leading cause of death in African-

Americans is cardiovascular disease. Although there have

been improvements in the treatment of heart disease and

stroke that, combined with preventive measures, have

reduced cardiovascular morbidity and mortality in this coun-

try, the improvements in cardiovascular outcomes in African-

Americans has lagged behind those of White Americans.

This conference focuses on evidence-based treatments that

prevent and retard the progression of cardiovascular disease

in African-Americans. Participants will also review certain

aspects of racial disparities in cardiovascular care while also

discussing possible solutions.

Sponsored by: The Ohio State University Medical Center in Cooperation with Ohio State’s Heart and Vascular Center and Division of Cardiovascular Medicine

Target audience: • Cardiologists

• Internal Medicine Physicians

• Family Practice Physicians

• Fellows in Training

• Nurses

• Allied Health Professionals

At the conclusion of this activity, participants should be able to:• Describe the current epidemiology of cardiovascular disease in African-

Americans in the USA and the role of risk factors in African Americans

• Recognize the role of hospitals in racial disparities in cardiovascular care

• List three strategies to reduce racial disparities in cardiovascular care

• Describe the current approach to and management of acute ST segment elevation acute myocardial infarction

• Describe the concept of pharmacogenetics as it applies to hypertension in African-Americans

• Identify the epidemiology, medical management and surgical management of congestive heart failure in African-Americans

Sponsored by: The Ohio State University Medical Center in Cooperation with Ohio State’s Heart and Vascular Center and Division of Cardiovascular Medicine

FeaturingClyde Yancy, MD, MSc Magerstadt Professor Chief, Division of Cardiology Northwestern Memorial Hospital Northwestern Feinberg School of Medicine

Clyde Yancy, MD, MSc, is the Magerstadt Professor and chief of the Division of Cardiology at Northwestern University Feinberg School of Medicine and associ-ate director of The Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. Until recently Dr. Yancy was the medical director at Baylor Heart and Vascular Institute and chief of Cardiothoracic Transplantation at Baylor University Medical Center. He co-chairs the Coalition to Reduce Racial and Ethnic Dispari-ties in Cardiovascular Outcomes sponsored by the American College of Cardiol-ogy (ACC). He has served as president of the American Heart Association (AHA) and on the Executive Council of the Heart Failure Society of America. He is a member of the ACC Guideline Taskforce that oversees all ACC/AHA guidelines. His research interests include the emerging role of registries in cardiovascular diseases, management of advanced heart failure with new drugs and devices and heart failure in special populations.

And

Herman Taylor, MD, MPH Professor of Medicine University of Mississippi Medical Center Clinical Professor of Epidemiology and Preventive Medicine Jackson State University Director/Principal Investigator of the Jackson Heart Study Jackson, Mississippi

Herman A. Taylor, MD, MPH, is Professor of Medicine at University of Mississippi Medical Center, Clinical Professor of Epidemiology and Preventive Medicine at Jackson State University, and Director/Principal Investigator of the Jackson Heart Study (JHS) in Jackson, Mississippi. The landmark JHS is the largest population-based study of heart and related diseases ever undertaken in African Americans. While the study seeks to answer questions about cardiovascular disease risk in the African-American population, it also provides historically black colleges and universities experience in large-scale epidemiological research. In addition, a new generation of African-American students is able to prepare for leadership roles in science and medicine. The JHS is funded by the National Heart, Lung and Blood Institute and the National Center on Minority Health and Health Disparities of the National Institutes of Health.

The Third Annual Cardiovascular Disease in African-Americans Conference April 21, 2011

 

The Third Annual Cardiovascular Disease in African-Americans Conference April 21, 2011

Agenda

11:30 a.m. Lunch and Registration

1 p.m. Welcome William Abraham, MD Quinn Capers IV, MD, Course Director

Cardiomyopathy and Heart Failure

1:15 p.m. Evidence-Based Management of Diastolic Congestive Heart Failure and the Promise of Implanted Hemodynamic Monitoring Devices William Abraham, MD

1:35 p.m. Evidence-Based Management of Systolic Congestive Heart Failure Clyde Yancy, MD,MSc

1:55 p.m. Evidence-Based Approach to the Prevention and Management of Cardiac Arrest David Hart, MBBS

2:15 p.m. Cardiac Transplantation in African-Americans Robert Higgins, MD, MSHA

2:35 p.m. Break/Refreshments

Special Considerations in Epidemiology

2:50 p.m. Update on the Jackson Heart Study: The “Black Framingham” Herman Taylor, MD, MPH

3:10 p.m. Focus on African-American Women: Epidemiology and Approach to Prevention and Management of Cardiovascular Disease Martha Gulati, MD

3:30 p.m. Air Pollution as a Risk Factor for Cardiac Disease: What is the Evidence? Sanjay Rajagopalan, MBBS

Agenda cont.

3:50 p.m. Evidence-Based Management of Acute ST elevation MI in African-Americans Quinn Capers IV, MD

4:10 p.m. Evidence-Based Management of HTN in African-Americans: Impact of Genetics on Pharmacotherapy Gbemiga Sofowora, MB/ChB

4:30 p.m. Break/Refreshments

Update on Racial Disparities in Cardiovascular Care

4:45 p.m. Update on Racial Disparities in Cardiovascular Care: Focus on Hospital Quality Quinn Capers IV, MD

5:05 p.m. A Prescription to Eliminate or Reduce Racial Disparities in Cardiovascular Care Clyde Yancy, MD, MSc

5:25 p.m. Closing Comments Thomas Ryan, MD

5:30 p.m. Course Adjourns

William Abraham, MDProfessor of Internal Medicine and of Physiology and Cell BiologyChair of Excellence in Cardiovascular MedicineDirector, Division of Cardiovascular Medicine

Quinn Capers IV, MDCourse DirectorAssistant Professor of Clinical Internal MedicineAssociate Dean for Admissions at Ohio State’s College of MedicineDirector of Peripheral Vascular Interventions

Martha Gulati, MDSarah Ross Soter Chair in Women’s Cardiovas-cular Health at The Ohio State UniversitySection Director for Preventive Cardiology and Women’s Cardiovascular HealthAssociate Professor of Clinical in the Depart-ment of Internal Medicine

David Hart, MBBSAssistant Professor of Clinical Internal MedicineDivision of Cardiovascular Medicine

The Ohio State University Medical Center Faculty

The Third Annual Cardiovascular Disease in African-Americans Conference April 21, 2011

Robert Higgins, MD, MSHAJohn H. and Mildred C. Lumley Chair in MedicineDirector of Ohio State’s Comprehensive Transplant CenterProfessor and Director of the Division of Cardiac Surgery

Sanjay Rajagopalan, MBBSJohn W. Wolfe Professor in Cardiovascular Research Section Director of Vascular MedicineCo-Director Ohio State’s Cardiovascular MR/CT Program

Thomas Ryan, MDDirector of Ohio State’s Heart and Vascular CenterJohn G. & Jeanne Bonnet McCoy Chair in Cardio-vascular MedicineProfessor in the Department of Internal Medicine

Gbemiga Sofowora, MB/ChBAssistant Professor of Clinical Internal MedicineOhio State’s Division of Cardiovascular Medicine

Guest FacultyHerman Taylor, MD, MPHProfessor of MedicineUniversity of Mississippi Medical CenterClinical Professor of Epidemiology and Preventive MedicineJackson State UniversityDirector/Principal Investigator of the Jackson Heart StudyJackson, Mississippi

Clyde Yancy, MD, MScMagerstadt ProfessorChief of the Division of CardiologyNorthwestern Memorial HospitalNorthwestern Feinberg School of MedicineChicago, Illinois

Accreditation: The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

The Ohio State University Medical Center designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim credit commensurate with the extent of their participation in the activity.

This course is free, but seating is limited and registration required. To register, visit ccme.osu.edu and click “Show all Conferences.” Fax registration form to 614-292-9761 or mail your completed registration form to:

The Ohio State University Medical CenterDivision of Cardiovascular MedicineDavis Heart & Lung Research InstituteSte 226, Attn: Ellen Yokoyama473 W. 12th AveColumbus, OH 43210

If you have any questions, please call Ellen Yokoyama at 614-247-7448.

Name Degree

Specialty

Address

City State ZIP

Phone Fax Email

The Third Annual Cardiovascular Disease in African-Americans Conference April 21, 2011

The

Ohi

o St

ate

Uni

vers

ity H

eart

and

Vas

cula

r C

ente

rPO

Box

18

310

1C

olum

bus,

OH

432

18

Apr

il 21

Feat

urin

g C

lyde

Yan

cy, M

D, M

ScM

ager

stad

t Pro

fess

orC

hief

, Div

isio

n of

Car

diol

ogy

Nor

thw

este

rn M

emor

ial H

ospi

tal

Nor

thw

este

rn F

einb

erg

Scho

ol o

f Med

icin

e

Pres

ort

Firs

t Cla

ssU

.S. P

osta

gePA

IDC

olum

bus,

OH

Perm

it N

o. 7

11

The

Third

Ann

ual

Car

diov

ascu

lar D

iseas

e in

A

fric

an-A

mer

ican

s Con

fere

nce